tipidogrel
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 9, 2024 (NCT06584812)
Timeline
Indications
Mechanism of action
- Purinergic receptor P2Y12INHIBITOR
P2RY12 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06601127 | Phase 2 | Oct 10, 2024 | Government of China |
| NCT06584812 | Phase 1 | Sep 9, 2024 | Government of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1